Patents by Inventor Jiehui Deng

Jiehui Deng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination therapy for treatment of LKB1 deficient cancers
    Patent number: 11944615
    Abstract: Provided are methods of sensitizing LKB1/STK11 deficient cancers to immune therapy. A method for treatment for LKB1/STK11 deficient cancers is provided comprising administration of inhibitor or inhibitors of one or more of NAMPT, CD38, SHP2, CXCR1/2, HDAC4 and PARP in combination with immunotherapy.
    Type: Grant
    Filed: September 3, 2021
    Date of Patent: April 2, 2024
    Assignee: New York University
    Inventors: David Peng, Kwok-Kin Wong, Jiehui Deng
  • COMBINATION THERAPY FOR TREATMENT OF LKB1 DEFICIENT CANCERS
    Publication number: 20220062260
    Abstract: Provided are methods of sensitizing LKB1/STK11 deficient cancers to immune therapy. A method for treatment for LKB1/STK11 deficient cancers is provided comprising administration of inhibitor or inhibitors of one or more of NAMPT, CD38, SHP2, CXCR1/2, HDAC4 and PARP in combination with immunotherapy.
    Type: Application
    Filed: September 3, 2021
    Publication date: March 3, 2022
    Inventors: David Peng, Kwok-Kin Wong, Jiehui Deng